DirectHit® Test Panel for Breast Cancer helps physicians predict which anticancer therapy
treatments will be the most effective for individual breast cancer patients.
Clinical trial results show that DirectHit® predicts, with a high degree of accuracy,
the tumor’s resistance and sensitivity to four commonly prescribed classes of breast
cancer treatments.